Deep Track Capital »

Tg Therapeutics shares owned by Deep Track Capital

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $51M 2.9M 17.79

More positions owned by Deep Track Capital

Amgen (AMGN)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Springworks Therapeutics (SWTX)
Insmed Com Par $.01 (INSM)
Guardant Health (GH)
Dynavax Technologies Corp Com New (DVAX)
Alnylam Pharmaceuticals (ALNY)
Intellia Therapeutics (NTLA)
Intra Cellular Therapies (ITCI)
Apellis Pharmaceuticals (APLS)
Ionis Pharmaceuticals (IONS)
Ocular Therapeutix (OCUL)
4d Molecular Therapeutics In (FDMT)

View all positions for Deep Track Capital

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Geode Capital Management
Deep Track Capital
Susquehanna International
Citadel Advisors
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Marshall Wace
Sofinnova Ventures
Nuveen Asset Management
Morgan Stanley

View all funds holding Tg Therapeutics